Abstract | BACKGROUND: METHODS: RESULTS: Following therapy with pentoxifylline and tocopherol, 76% (19/25) of the patients showed complete mucosal healing, in which 47.3% (9/19) did not undergo sequestrectomy. From this particular group, 77.7% (7/9) were in stage I and 33.3% (3/9) used the protocol for up to 3 months. Among those who underwent to sequestrectomy, complete mucosal healing was observed in 52.7% (10/19). Among these, 60% (6/10) were in stage I and 100% of the patients were using the protocol for more than 3 months. In all other patients, partial healing of the mucosa was observed since they presented advanced disease. These represented 24% of the sample (6/25), 66.6% (4/6) were in stage III, and 60% (4/6) used the protocol for over 6 months. CONCLUSION:
|
Authors | Raíssa Soares Dos Anjos, Giovana Nóbrega de Pádua Walfrido, Rômulo Oliveira de Hollanda Valente, Luiz Alcino Gueiros, Alessandra Albuquerque Tavares Carvalho, Preeyan Patel, Stephen Porter, Jair Carneiro Leão, Igor Henrique Morais Silva |
Journal | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
(Support Care Cancer)
Vol. 29
Issue 6
Pg. 3311-3317
(Jun 2021)
ISSN: 1433-7339 [Electronic] Germany |
PMID | 33106977
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antioxidants
- Platelet Aggregation Inhibitors
- Tocopherols
- Pentoxifylline
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antioxidants
(pharmacology, therapeutic use)
- Female
- Humans
- Jaw
(pathology)
- Male
- Middle Aged
- Osteoradionecrosis
(drug therapy, pathology, surgery)
- Pentoxifylline
(pharmacology, therapeutic use)
- Platelet Aggregation Inhibitors
(pharmacology, therapeutic use)
- Tocopherols
(pharmacology, therapeutic use)
|